Spain will join Gavi in co-hosting a high-level global summit bringing together global health stakeholders from multilateral organisations, governments, civil society, business and academia to take stock of the state of vaccination in Gavi-supported lower-income countries and look to the future.

This Summit will provide an opportunity to look at the impact achieved by the Vaccine Alliance during its current strategic period, which began in January 2021. Gavi and its partners faced the dual challenge of supporting routine immunisation while also responding to a once-in-a-century pandemic. Despite severe disruption, this period saw resilience, with more vaccines administered by lower-income countries in 2021 than at any other time in history and an increase in coverage for rotavirus vaccine, the second dose of measles-containing vaccine and pneumococcal conjugate vaccine.